Logo image of CBPO

China Biologic Produ (CBPO) Stock Fundamental Analysis

USA - NASDAQ:CBPO -

119.99
+1.98 (+1.68%)
Last: 4/20/2021, 8:09:52 PM
120.04
+0.05 (+0.04%)
After Hours: 4/20/2021, 8:09:52 PM
No Fundamental Analysis report for CBPO not available.

China Biologic Produ

NASDAQ:CBPO (4/20/2021, 8:09:52 PM)

After market: 120.04 +0.05 (+0.04%)

119.99

+1.98 (+1.68%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.62%
Inst Owner Change0%
Ins Owners39.98%
Ins Owner Change0%
Market Cap4.72B
Revenue(TTM)524.37M
Net Income(TTM)152.29M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP8.12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30.07
Fwd PE 27.9
P/S 9.01
P/FCF N/A
P/OCF N/A
P/B 2.39
P/tB N/A
EV/EBITDA 18.67
EPS(TTM)3.99
EY3.33%
EPS(NY)4.3
Fwd EY3.58%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.32
BVpS50.2
TBVpSN/A
PEG (NY)3.87
PEG (5Y)7.41
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.12%
ROE 7.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 37.26%
PM (TTM) 29.04%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.01
Quick Ratio 12.01
Altman-Z 19.23
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.78%
EPS 3YN/A
EPS 5Y4.06%
EPS Q2Q%-25.71%
EPS Next Y7.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.09%
Revenue growth 3YN/A
Revenue growth 5Y12.08%
Sales Q2Q%1.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

China Biologic Produ / CBPO FAQ

Can you provide the ChartMill fundamental rating for China Biologic Produ?

ChartMill assigns a fundamental rating of 5 / 10 to CBPO.


What is the valuation status for CBPO stock?

ChartMill assigns a valuation rating of 2 / 10 to China Biologic Produ (CBPO). This can be considered as Overvalued.


How profitable is China Biologic Produ (CBPO) stock?

China Biologic Produ (CBPO) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CBPO stock?

The Price/Earnings (PE) ratio for China Biologic Produ (CBPO) is 30.07 and the Price/Book (PB) ratio is 2.39.


Is the dividend of China Biologic Produ sustainable?

The dividend rating of China Biologic Produ (CBPO) is 0 / 10 and the dividend payout ratio is 8.12%.